HK1169404A1 - Intermediates and processes for the preparation of 4- (acetylamino)) -3- [(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid - Google Patents

Intermediates and processes for the preparation of 4- (acetylamino)) -3- [(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid

Info

Publication number
HK1169404A1
HK1169404A1 HK12110140.4A HK12110140A HK1169404A1 HK 1169404 A1 HK1169404 A1 HK 1169404A1 HK 12110140 A HK12110140 A HK 12110140A HK 1169404 A1 HK1169404 A1 HK 1169404A1
Authority
HK
Hong Kong
Prior art keywords
acetylamino
indole
thio
intermediates
chloro
Prior art date
Application number
HK12110140.4A
Other languages
English (en)
Inventor
Debra Ainge
Michael Butters
Eric Merifield
Ravi Ramakrishnan
Ravi Naidu Rayapati
Parhalad Ray Sharma
Colin Thomson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1169404A1 publication Critical patent/HK1169404A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
HK12110140.4A 2009-07-06 2012-10-13 Intermediates and processes for the preparation of 4- (acetylamino)) -3- [(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid HK1169404A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22316309P 2009-07-06 2009-07-06
PCT/GB2010/051100 WO2011004182A1 (en) 2009-07-06 2010-07-05 Intermediates and processes for the preparation of 4- (acetylamino) ) -3- [ (4-chloro-phenyl) thio] -2-methyl-1h-indole-1-acetic acid

Publications (1)

Publication Number Publication Date
HK1169404A1 true HK1169404A1 (en) 2013-01-25

Family

ID=42780497

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12110140.4A HK1169404A1 (en) 2009-07-06 2012-10-13 Intermediates and processes for the preparation of 4- (acetylamino)) -3- [(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid

Country Status (17)

Country Link
US (1) US8227622B2 (xx)
EP (1) EP2451780B1 (xx)
JP (1) JP5675800B2 (xx)
KR (1) KR101752932B1 (xx)
CN (1) CN102482214B (xx)
AR (1) AR077457A1 (xx)
AU (1) AU2010270050B9 (xx)
BR (1) BR112012000353B1 (xx)
CA (1) CA2767132C (xx)
ES (1) ES2426679T3 (xx)
HK (1) HK1169404A1 (xx)
IL (1) IL217088A0 (xx)
MX (1) MX2012000229A (xx)
RU (1) RU2551852C2 (xx)
SG (1) SG177286A1 (xx)
TW (1) TW201118067A (xx)
WO (1) WO2011004182A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104817544B (zh) * 2015-03-23 2017-05-10 三峡大学 一种四氢吲哚‑4‑酮肟类药物,制备方法及其应用
JP6452584B2 (ja) * 2015-09-30 2019-01-16 富士フイルム株式会社 芳香族化合物の製造方法
JP6472419B2 (ja) * 2015-09-30 2019-02-20 富士フイルム株式会社 芳香族化合物の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
TWI317634B (en) 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
GB0428100D0 (en) 2004-12-23 2005-01-26 Astrazeneca Ab Chemical processes & intermediates
GB0500604D0 (en) * 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
JP2009538289A (ja) 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
RU2008152763A (ru) 2006-06-08 2010-07-20 Ньюроки А/С (Dk) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
KR20090023645A (ko) 2006-06-28 2009-03-05 사노피-아벤티스 신규한 cxcr2 억제제

Also Published As

Publication number Publication date
RU2551852C2 (ru) 2015-05-27
TW201118067A (en) 2011-06-01
SG177286A1 (en) 2012-02-28
KR101752932B1 (ko) 2017-07-03
KR20120030525A (ko) 2012-03-28
BR112012000353B1 (pt) 2020-06-02
AU2010270050A1 (en) 2012-02-02
CA2767132A1 (en) 2011-01-13
ES2426679T3 (es) 2013-10-24
CA2767132C (en) 2017-06-20
WO2011004182A1 (en) 2011-01-13
BR112012000353A2 (pt) 2017-06-13
US20110046394A1 (en) 2011-02-24
RU2012103466A (ru) 2013-08-20
JP5675800B2 (ja) 2015-02-25
CN102482214A (zh) 2012-05-30
IL217088A0 (en) 2012-02-29
AR077457A1 (es) 2011-08-31
AU2010270050B2 (en) 2013-06-06
US8227622B2 (en) 2012-07-24
AU2010270050B9 (en) 2013-06-27
CN102482214B (zh) 2014-08-27
EP2451780A1 (en) 2012-05-16
MX2012000229A (es) 2012-01-25
JP2012532186A (ja) 2012-12-13
EP2451780B1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
EP2501423A4 (en) NOSE MASK
GB2467610B (en) Elevator and method of use
IL206664A0 (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
IL221001A (en) An aqueous adhesive and a process for its manufacture
ZA201108502B (en) Processes and intermediates
PL2627656T3 (pl) Sposób wytwarzania dihydropterydynonów i ich produktów pośrednich
EP2475701A4 (en) NEW THIOVER BINDINGS AND METHOD FOR THEIR MANUFACTURE
EP2496553A4 (en) NEW METHOD FOR THE PRODUCTION OF PROSTAGLANDINES AND INTERMEDIATE PRODUCTS THEREOF
IL216650A0 (en) Process for the preparation and purification of etravirine and intermediates thereof
EP2426131A4 (en) CARBAPENEM INTERMEDIATES, COMPOSITIONS AND METHOD OF PREPARATION THEREFOR
EP2182803A4 (en) (4-METHOXY-7-MORPHOLIN-4-YL-BENZOTHIAZOL-2-YL) -AMIDE 4-HYDROXY-4-METHYL-PIPERIDINE-1-CARBOXYLIC ACID FOR TREATING POST-TRAUMATIC STRESS DISORDER
HK1169404A1 (en) Intermediates and processes for the preparation of 4- (acetylamino)) -3- [(4-chloro-phenyl) thio]-2-methyl-1h-indole-1-acetic acid
EP2507197A4 (en) CYCLOHEXANOXIDE WITH HIGH SCRUB
PL2509876T3 (pl) Karton i sposób jego wytwarzania
TWI372082B (en) Paste dispenser and method of controlling the same
GB0915034D0 (en) Nasal sucker
EP2643308A4 (en) PROCESS FOR THE PREPARATION OF TAUROLIDINE AND ITS INTERMEDIATE PRODUCTS
EP2440415A4 (en) MATRIX ALIGNMENT
EP2467375A4 (en) FORMS OF DEXLANDSOPRAZOLE AND METHOD OF MANUFACTURING THEREOF
ZA201202799B (en) Method and formulation for the control of parasites
GB0811625D0 (en) Treatment of epithelial fragility disorders
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
AU2009901705A0 (en) Nose shade - Promotional
AU2008900387A0 (en) Calculation of optimal maintenance schedules
AU2009901105A0 (en) Electrorecovery of metals

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210705